[144] Disc Medicine, Inc. SEC Filing

Rhea-AI Filing Summary

Disc Medicine, Inc. (IRON) submitted a Form 144 proposing the sale of 7,212 shares of Common Stock through Merrill Lynch, with an aggregate market value of $440,653.20. The filing lists 34,765,581 shares outstanding and an approximate sale date of 08/14/2025 on Nasdaq. The shares were originally acquired in a private placement on 05/01/2020 from the issuer and paid in cash. The filer reports no securities sold in the past three months and includes the standard representation about no undisclosed material information and compliance with Rule 10b5-1 if applicable.

Positive

• Full Rule 144 disclosure: The filing provides broker details, share counts, acquisition date, payment method, and sale date, supporting regulatory transparency.
• Clear acquisition history: The securities were acquired via private placement on 05/01/2020 and paid in cash, explicitly disclosed in the form.

Negative

• Insider sale proposed: The notice indicates a planned disposition of common stock by an insider or affiliate, which investors may view negatively.
• Market impact risk: Although small in absolute terms, the sale increases share supply and could have localized price effects around the sale date.

Insights

Securities Analyst

TL;DR: Small proposed sale filed under Rule 144; limited market impact given size relative to outstanding shares.

The filer proposes to sell 7,212 common shares valued at $440,653.20, with 34,765,581 shares outstanding and the sale routed through Merrill Lynch on Nasdaq. The shares were acquired in a private placement on 05/01/2020 and paid in cash. Because no sales were reported in the last three months, this filing appears to disclose a planned disposition rather than an ongoing selling program. Based solely on the filing, the transaction's absolute size is modest relative to total outstanding shares.

Compliance Officer

TL;DR: Form 144 appears to meet Rule 144 disclosure requirements; includes required representations and transaction details.

The notice identifies the broker, class of security, acquisition date and nature (private placement), payment method (cash), and an approximate sale date of 08/14/2025. It also includes the signature representations about material nonpublic information and references Rule 10b5-1 when applicable. From a compliance perspective, the filing supplies the core elements regulators expect in a Form 144 submission.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch One Bryant Park New York NY 10036	7212	440653.20	34765581	08/14/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/01/2020	Private Placement	Issuer			7212	05/01/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Disc Medicine's (IRON) Form 144 disclose about the planned sale?

The Form 144 discloses a proposed sale of 7,212 common shares through Merrill Lynch with an aggregate market value of $440,653.20 and an approximate sale date of 08/14/2025 on Nasdaq.

When and how were the shares being offered in the IRON Form 144 acquired?

The filing states the shares were acquired in a private placement on 05/01/2020 from the issuer, and payment was made in cash on the acquisition date.

Does the Form 144 show recent sales by the filer for IRON in the past three months?

No. The section 'Securities Sold During The Past 3 Months' is marked as Nothing to Report.

Which broker is handling the proposed IRON share sale and where will it trade?

The proposed sale lists Merrill Lynch One Bryant Park New York NY 10036 as the broker and indicates the shares are to be sold on Nasdaq.

How many shares outstanding does Disc Medicine report in the filing?

The filing reports 34,765,581 shares outstanding.